<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01659060</url>
  </required_header>
  <id_info>
    <org_study_id>119.05.03</org_study_id>
    <nct_id>NCT01659060</nct_id>
  </id_info>
  <brief_title>Chocolate Consumption in Healthy Pregnant Women Trial</brief_title>
  <official_title>Assessment of Blood Pressure and Endothelial Function Pregnancy After Acute and Daily Consumption Flavanol-rich Chocolate Among Healthy Pregnant Women: a Pilot Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laval University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laval University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to to test the feasibility of design methods and procedures for
      later use on a larger scale and to examine the acute and chronic effect of consumption of
      flavanol-rich chocolate on endothelium function and blood pressure in healthy pregnant women.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">April 2009</completion_date>
  <primary_completion_date type="Actual">April 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in endothelial function and blood pressure</measure>
    <time_frame>within the first 12 weeks of chocolate intake (week 12 and baseline)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes from baseline in plasma flavanol and methylxanthines(caffeine, theobromine and theophylline) concentrations at 12 weeks</measure>
    <time_frame>within the first 12 weeks of chocolate intake (week 12 and baseline)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight change from baseline at 12 weeks</measure>
    <time_frame>within the first 12 weeks of chocolate intake (week 12 and baseline)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with digestive and other signs and symptoms (nausea, abdominal pain, constipation, and headache)</measure>
    <time_frame>within the first 12 weeks of chocolate intake (week 12 and baseline)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Hypertension Pregnancy-induced</condition>
  <arm_group>
    <arm_group_label>Dark chocolate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo chocolate</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Flavanol-rich dark chocolate</intervention_name>
    <description>The primary objective of this pilot RCT is to test the feasibility of design methods and procedures for later use on a larger scale. The secondary objective is to examine the acute and chronic effect of dark chocolate on endothelial function and blood pressure, among healthy pregnant women.</description>
    <arm_group_label>Dark chocolate</arm_group_label>
    <other_name>Chocolate rich in flavanols</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo Chocolate</intervention_name>
    <description>Placebo intervention</description>
    <arm_group_label>Placebo chocolate</arm_group_label>
    <other_name>Flavanol-free chocolate</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  non-smoking normotensive women aged from 18 to 35 years, between the 7 and 12 weeks of
             gestation (documented by ultrasound) and having a live fetus confirmed by fetal heart
             auscultation

        Exclusion Criteria:

          -  Patients with family history of premature cardiovascular disease

          -  Chronic hypertension

          -  Currently or previously use of medications interfering with glucose or lipids
             metabolism.

          -  Use of supplements or natural health products that interfere with blood pressure.

          -  Consumption of 1 or more alcohol drink per day.

          -  Allergy or intolerance to nuts or chocolate.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sylvie Dodin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Laval University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Laval University, Department of Medicine, Institut des nutraceutiques et des aliments fonctionnels</name>
      <address>
        <city>Qu√©bec</city>
        <state>Quebec</state>
        <zip>G1V 0A6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 31, 2012</study_first_submitted>
  <study_first_submitted_qc>August 2, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 7, 2012</study_first_posted>
  <last_update_submitted>August 2, 2012</last_update_submitted>
  <last_update_submitted_qc>August 2, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 7, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cacao</keyword>
  <keyword>Chocolate</keyword>
  <keyword>Theobromine</keyword>
  <keyword>Flavonoids</keyword>
  <keyword>Pregnant women</keyword>
  <keyword>Hypertension pregnancy-induced</keyword>
  <keyword>Pre-eclampsia</keyword>
  <keyword>Epicatechin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Pre-Eclampsia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

